Cabaletta Bio, Inc. SEC filings CABA
Cabaletta Bio, Inc. has 448 filings in SEC EDGAR's recent list, going back to Dec 10, 2018. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 15, 2025 | — |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| EFFECT | Filing | Mar 31, 2025 | — |
| POSASR | Filing | Mar 31, 2025 | — |
| EFFECT | Filing | Apr 26, 2023 | — |
| CORRESP | Letter to the SEC | Apr 24, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2023 | — |
| EFFECT | Filing | Nov 18, 2020 | — |
| CORRESP | Letter to the SEC | Nov 16, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2020 | — |
| EFFECT | Filing | Oct 24, 2019 | — |
| CERT | 8a cert | Oct 24, 2019 | — |
| 8-A12B | Filing | Oct 23, 2019 | — |
| SEC STAFF LETTER | Filing | Oct 22, 2019 | — |
| CORRESP | Letter to the SEC | Oct 22, 2019 | — |
| CORRESP | Letter to the SEC | Oct 22, 2019 | — |
| CORRESP | Letter to the SEC | Oct 11, 2019 | — |
| CORRESP | Letter to the SEC | Oct 9, 2019 | — |
| CORRESP | Letter to the SEC | Sep 30, 2019 | — |
| DRSLTR | Filing | Sep 20, 2019 | — |
| DRS/A | Filing | Sep 20, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2019 | — |
| DRSLTR | Filing | Sep 6, 2019 | — |
| DRS/A | Filing | Sep 6, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2019 | — |
| SEC STAFF LETTER | Filing | Aug 21, 2019 | — |
| DRS | Filing | Aug 2, 2019 | — |
| D | Filing | Jan 14, 2019 | — |
| D | Filing | Dec 10, 2018 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CABA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1759138
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.